Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) EBT Margin (2017 - 2025)

Catheter Precision (VTAK) has disclosed EBT Margin for 8 consecutive years, with 1002.65% as the latest value for Q3 2025.

  • On a quarterly basis, EBT Margin rose 328901.0% to 1002.65% in Q3 2025 year-over-year; TTM through Sep 2025 was 2182.19%, a 74613.0% increase, with the full-year FY2024 number at 3214.76%, up 1275175.0% from a year prior.
  • EBT Margin was 1002.65% for Q3 2025 at Catheter Precision, up from 3022.64% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 834.98% in Q4 2021 to a low of 171925.0% in Q1 2021.
  • A 5-year average of 38355.27% and a median of 3262.2% in 2024 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: tumbled -17136452bps in 2021, then skyrocketed 16731833bps in 2023.
  • Catheter Precision's EBT Margin stood at 834.98% in 2021, then crashed by -20335bps to 168960.0% in 2022, then surged by 100bps to 522.66% in 2023, then plummeted by -219bps to 1669.13% in 2024, then surged by 40bps to 1002.65% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EBT Margin are 1002.65% (Q3 2025), 3022.64% (Q2 2025), and 3334.97% (Q1 2025).